Brendan Teehan
Chief Operating Officer en ACADIA PHARMACEUTICALS INC. .
Fortuna: 779 039 $ al 31/03/2024
Perfil
Brendan P.
Teehan is currently the Chief Operating Officer, EVP & Head-Commercial at ACADIA Pharmaceuticals, Inc. He previously worked as the Vice President-Building & Provider Solutions at Tesaro, Inc. from 2016 to 2018, and as the Senior Vice President & Vice President at RT Oncology Services Corp.
from 2012 to 2016.
Mr. Teehan holds an MBA degree from Carnegie Mellon University and an undergraduate degree from the University of Notre Dame, which he received in 1990.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
02/05/2024 | 42 133 ( 0.03% ) | 779 039 $ | 31/03/2024 |
Cargos activos de Brendan Teehan
Empresas | Cargo | Inicio |
---|---|---|
ACADIA PHARMACEUTICALS INC. | Chief Operating Officer | 01/11/2021 |
Antiguos cargos conocidos de Brendan Teehan.
Empresas | Cargo | Fin |
---|---|---|
TESARO INC | Corporate Officer/Principal | 01/07/2018 |
RT Oncology Services Corp.
RT Oncology Services Corp. Miscellaneous Commercial ServicesCommercial Services RT Oncology Services Corp. is a holding company, which engages in the provision of oncology related assistance services. It assists its member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices. The company was founded by Michael J. Martin, John Creelman, and Jeffrey Patton in 2011 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/04/2016 |
Formación de Brendan Teehan.
Carnegie Mellon University | Masters Business Admin |
University of Notre Dame | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ACADIA PHARMACEUTICALS INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
RT Oncology Services Corp.
RT Oncology Services Corp. Miscellaneous Commercial ServicesCommercial Services RT Oncology Services Corp. is a holding company, which engages in the provision of oncology related assistance services. It assists its member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices. The company was founded by Michael J. Martin, John Creelman, and Jeffrey Patton in 2011 and is headquartered in San Diego, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Brendan Teehan